{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:00:59Z","timestamp":1780426859275,"version":"3.54.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"abstract":"<jats:p>\n                    This study aimed to investigate the prognostic factors of febrile neutropenic patients during colistin treatment. The indications for starting colistin treatment during febrile neutropenia (FN) episodes, nephrotoxicity, FN-related mortality rates, and the presence of isolated gram-negative bacteria in cultures were examined before initiating colistin treatment. This study included a total of 160 participants. The time from fever onset to colistin initiation was\u2005\u2264\u20055 days in 23 patients and\u2005&gt;\u20055 days in 137 patients. When colistin treatment was initiated, 70 patients had sepsis or septic shock. There were 24% of patients had invasive pulmonary aspergillosis. Acute kidney injury occurred in 38 patients (24%).\n                    <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                    (41%),\n                    <jats:italic toggle=\"yes\">Acinetobacter baumannii<\/jats:italic>\n                    (30%), and\n                    <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>\n                    (19%) were the most frequently isolated gram-negative bacteria. When these variables were included in the multivariate Cox regression model, the risk of mortality increased if colistin was started after the fifth day (hazard ratio [HR], 7.78; 95% confidence interval [95% CI], 1.89\u201331.95), patients had sepsis or septic shock (HR, 5.02; 95% CI, 2.03\u201312.37), patients had\n                    <jats:italic toggle=\"yes\">K. pneumoniae<\/jats:italic>\n                    (HR, 3.06; 95% CI, 1.06\u20138.82) and\n                    <jats:italic toggle=\"yes\">A. baumannii<\/jats:italic>\n                    infection (HR, 10.37; 95% CI, 2.91\u201336.92), and whether the patient had probable invasive pulmonary aspergillosis (HR, 6.51; 95% CI, 1.99\u201321.22). Culture-positive patients had a higher FN-related mortality rate than culture-negative patients (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.04). In the presence of prognostic factors in our risk model, the early initiation of colistin therapy may reduce mortality.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044841","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:00:34Z","timestamp":1759248034000},"page":"e44841","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Risk factors for mortality in febrile neutropenic patients treated with colistin"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5129-2977","authenticated-orcid":false,"given":"Cumali","family":"Yal\u00e7in","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Division of Hematology, Department of Internal Medicine, Bursa Uludag University, Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vildan","family":"\u00d6zkocaman","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Hematology, Department of Internal Medicine, Bursa Uludag University, Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba","family":"Ersal","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Hematology, Department of Internal Medicine, Bursa Uludag University, Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedrettin","family":"Orhan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Hematology, Department of Internal Medicine, Bursa Uludag University, Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer","family":"Candar","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Hematology, Department of Internal Medicine, Bursa Uludag University, Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinem","family":"\u00c7ubuk\u00e7u","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Hematology, Department of Internal Medicine, Bursa Uludag University, Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba G\u00fcll\u00fc","family":"Koca","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Hematology, Department of Internal Medicine, Bursa Uludag University, Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazil \u00c7a\u011fri","family":"Hunutlu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Hematology, Department of Internal Medicine, Bursa Uludag University, Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve Nur","family":"Akyol","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Internal Medicine, Bursa Uludag University, Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Kazak","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Bursa Uludag University, Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00fcneyt","family":"\u00d6zakin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Microbiology, Bursa Uludag University, Bursa, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halis","family":"Akalin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Bursa Uludag University, Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahir","family":"\u00d6zkalemka\u015f","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Hematology, Department of Internal Medicine, Bursa Uludag University, Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260602","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/jac\/dkr239","article-title":"Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09).","volume":"66","author":"Gales","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R2-20260602","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.idc.2016.02.005","article-title":"Agents of last resort: polymyxin resistance.","volume":"30","author":"Kaye","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"R3-20260602","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/antibiotics8020052","article-title":"The continuing threat of methicillin-resistant Staphylococcus aureus.","volume":"8","author":"Gajdacs","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"R4-20260602","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","article-title":"Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"key":"R5-20260602","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"key":"R6-20260602","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2147\/IDR.S241263","article-title":"Epidemiology of febrile neutropenia episodes with gram-negative bacteria infection in patients who have undergone chemotherapy for hematologic malignancies: a retrospective study of 10 years\u2019 data from a single center.","volume":"13","author":"Zhang","year":"2020","journal-title":"Infect Drug Resist"},{"key":"R7-20260602","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00277-020-04144-w","article-title":"An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality.","volume":"99","author":"Kara Ali","year":"2020","journal-title":"Ann Hematol"},{"key":"R8-20260602","first-page":"415","article-title":"Treatments and predictors of mortality for carbapenem-resistant gram-negative bacilli infections in Malaysia: a retrospective cohort study.","volume":"7","author":"Abubakar","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"R9-20260602","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1007\/s00277-023-05411-2","article-title":"Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP.","volume":"102","author":"Kim","year":"2023","journal-title":"Ann Hematol"},{"key":"R10-20260602","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury.","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"R11-20260602","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R12-20260602","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R13-20260602","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijid.2020.05.100","article-title":"The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii.","volume":"97","author":"Katip","year":"2020","journal-title":"Int J Infect Dis"},{"key":"R16-20260602","doi-asserted-by":"crossref","first-page":"106806","DOI":"10.1016\/j.ijantimicag.2023.106806","article-title":"Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey.","volume":"61","author":"Trecarichi","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"R17-20260602","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/jac\/dkad003","article-title":"Critical role of the RpoE stress response pathway in polymyxin resistance of Escherichia coli.","volume":"78","author":"Zeng","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"R18-20260602","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s10096-016-2895-2","article-title":"Acinetobacter baumannii bacteraemia in patients with haematological malignancy: a multicentre retrospective study from the Infection Working Party of Jiangsu Society of Hematology.","volume":"36","author":"Wang","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R19-20260602","first-page":"1199","article-title":"[Clinical characteristics and risk factors for 30-day mortality in patients with hematologic diseases infected by carbapenem-resistant organisms].","volume":"31","author":"Chen","year":"2023","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"R20-20260602","doi-asserted-by":"crossref","first-page":"106554","DOI":"10.1016\/j.ijantimicag.2022.106554","article-title":"A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 endemic setting.","volume":"59","author":"Aslan","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"R21-20260602","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/cid\/ciw805","article-title":"Colistin resistance in carbapenem-resistant Klebsiella pneumoniae: laboratory detection and impact on mortality.","volume":"64","author":"Rojas","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R22-20260602","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s10096-020-04124-y","article-title":"Colistin resistance increases 28-day mortality in bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae.","volume":"40","author":"Balkan","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R23-20260602","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijid.2019.06.008","article-title":"The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.","volume":"86","author":"Menek\u015fe","year":"2019","journal-title":"Int J Infect Dis"},{"key":"R24-20260602","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jhin.2017.11.014","article-title":"Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections.","volume":"98","author":"Aydin","year":"2018","journal-title":"J Hosp Infect"},{"key":"R25-20260602","first-page":"1079","article-title":"Reduced mortality from KPC-K.pneumoniae bloodstream infection in high-risk patients with hematological malignancies colonized by KPC-K.pneumoniae.","volume":"21","author":"Micozzi","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R26-20260602","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ajh.24489","article-title":"Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.","volume":"91","author":"Trecarichi","year":"2016","journal-title":"Am J Hematol"},{"key":"R27-20260602","first-page":"157","article-title":"Colistin: an antibiotic and its role in multiresistant Gram-negative infections.","volume":"47","author":"Loho","year":"2015","journal-title":"Acta Med Indones"},{"key":"R28-20260602","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14787210.2023.2184346","article-title":"Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?","volume":"21","author":"Ardebili","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R29-20260602","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1128\/AAC.02634-15","article-title":"Multicenter prospective cohort study of renal failure in patients treated with colistin versus polymyxin B.","volume":"60","author":"Rigatto","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"R30-20260602","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2169\/internalmedicine.50.4270","article-title":"Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysis.","volume":"50","author":"Durakovic","year":"2011","journal-title":"Intern Med"},{"key":"R31-20260602","doi-asserted-by":"crossref","first-page":"e01250","DOI":"10.1128\/AAC.01250-19","article-title":"Shock and early death in hematologic patients with febrile neutropenia.","volume":"63","author":"Guarana","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"R32-20260602","doi-asserted-by":"crossref","first-page":"878","DOI":"10.15537\/smj.2018.9.22824","article-title":"The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies.","volume":"39","author":"Calik","year":"2018","journal-title":"Saudi Med J"},{"key":"R33-20260602","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jinf.2023.01.026","article-title":"Empirical polymyxin B therapy in febrile neutropenic patients with hematological diseases: a prospective, multicenter, observational clinical study.","volume":"86","author":"Ma","year":"2023","journal-title":"J Infect"},{"key":"R34-20260602","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/0300060518811472","article-title":"Utility of serum galactomannan antigen testing combined with chest computed tomography for early diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies with febrile neutropenia after antifungal drug treatment.","volume":"47","author":"Wang","year":"2019","journal-title":"J Int Med Res"},{"key":"R35-20260602","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jmii.2018.01.002","article-title":"Clinical characteristics and treatment outcomes of pulmonary invasive fungal infection among adult patients with hematological malignancy in a medical centre in Taiwan, 2008-2013.","volume":"53","author":"Chen","year":"2020","journal-title":"J Microbiol Immunol Infect"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:00:57Z","timestamp":1780423257000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":33,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044841","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}